| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/22/2006 | EP1627057A2 Methods and compositions for the production of adenoviral vectors |
| 02/22/2006 | EP1370668B1 Leporipox-based vector vaccines |
| 02/22/2006 | EP1244805B1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 02/22/2006 | CN1738897A Genetic constructs and compositions comprising RRE and CTE and uses thereof |
| 02/22/2006 | CN1243099C Use and obtain of inactivating lumour CHK1 gene anticancer recombined gland virus constituent |
| 02/21/2006 | US7001764 Compositions comprising tissue specific adenoviral vectors |
| 02/21/2006 | US7001760 Hepatitis B virus vectors for gene therapy |
| 02/21/2006 | CA2356306C Sulfated phosphatidylinositols, their preparation and use |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/16/2006 | WO2005067506A3 Method for monitoring and generating high capacity gutless adenoviral vector |
| 02/16/2006 | US20060035378 Modified viral vector particles |
| 02/16/2006 | US20060035371 Hybrid adeno-retroviral vector for the transfection of cells |
| 02/16/2006 | US20060035364 combination of high ionic strength and modest osmolarity is achieved using salts of high valency, such as sodium citrate |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034860 Protein-protein interactions in human immunodeficiency virus |
| 02/16/2006 | US20060034859 Naturally processed measles virus peptides eluted from class II HLA molecules |
| 02/15/2006 | EP1626091A2 Duplexed parvovirus vectors |
| 02/15/2006 | EP1625852A1 Chimeric flavivirus vaccines |
| 02/15/2006 | EP1625214A1 New enterovirus, vaccines, medicaments and diagnostic kits |
| 02/15/2006 | EP1625210A2 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 02/15/2006 | EP1625205A2 Ancestral viruses and vaccines |
| 02/15/2006 | EP1456359B1 Preparation of vaccines using photosensitizer and light |
| 02/15/2006 | EP0946741B1 Method for producing recombinant virus |
| 02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
| 02/15/2006 | CN1733912A Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method |
| 02/15/2006 | CN1733911A Recombinant virus containing BPI gene and pharmaceutical composition containing same and uses |
| 02/15/2006 | CN1242065C Pig breeding and respiratory syndrome recombinant adenovirus and vaccine |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6998252 vaccinia virus modified by insertion of chimeric gene containing vaccinia regulatory sequences or DNA sequences functionally equivalent thereto flanking DNA sequences which to nature are not contiguous with flanking vaccinia regulatory dna sequence |
| 02/14/2006 | CA2242966C Method and apparatus for inactivating contaminants in biological fluid |
| 02/09/2006 | WO2005067643A3 Determination of hepatitis c virus genotype |
| 02/09/2006 | WO2005027825A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/09/2006 | WO2004113517A3 IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2003068923A3 Signal for packaging of influenza virus vectors |
| 02/09/2006 | US20060031968 Isolated plant deoxyhypusine synthase and nucleotides encoding same |
| 02/09/2006 | US20060030020 Lambdoid bacteriophage vectors for expression of foreign proteins |
| 02/09/2006 | US20060029928 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a |
| 02/09/2006 | US20060029619 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029598 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 02/09/2006 | US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs |
| 02/08/2006 | EP1623037A2 Improved method for producing non-pathogenic helper virus-free preparations of herpes virus amplicon vectors, the helper virus & the cells used in this method, the corresponding genetic tools, as well as the applications of these non-pathogenic amplicons vectors |
| 02/08/2006 | EP1623006A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 02/08/2006 | EP1622684A2 Compositions and methods relating to novel compounds and targets thereof |
| 02/08/2006 | EP1622574A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/08/2006 | CN1732267A Method of transferring gene into t cells |
| 02/07/2006 | US6995236 Sphingomyelin detecting probe |
| 02/07/2006 | US6995010 Two different adenoviral vectors for transferring a foreign gene into cell; a recombinase and a recombinase recognition sequence as the expression control system; improve efficiency of gene therapy; transformed cell |
| 02/07/2006 | US6995009 Virus-producing cell is used to produce retroviral vectors, for transfer the genes of interest into cells; produce infectious viruses at high titers, long-term stability and safety; prevent the emergence of wild type viruses |
| 02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
| 02/07/2006 | US6994858 Infecting the mixed cellular compositions with reovirus which selectively lyse the ras-mediated neoplastic cells in the mixed composition |
| 02/07/2006 | US6994851 cytotoxic T-lymphocyte (CTL) response; comprises placing a physiologically-acceptable, antigen-containing composition in a reservoir having a pump for delivering the composition at a defined rate through a transmission line |
| 02/06/2006 | CA2511314A1 Novel recombinant t4 phage particle and uses thereof |
| 02/02/2006 | WO2005068639A3 Particle-induced ghrelin immune response |
| 02/02/2006 | WO2005067543A3 Murine calicivirus |
| 02/02/2006 | US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 02/02/2006 | US20060024797 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024668 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/02/2006 | US20060024320 Attenuated pestiviruses |
| 02/02/2006 | US20060024319 determining whether a mouse is infected with murine norovirus-1 by determining presence, absence or quantity of antibody against MNV-1 a sample of a mouse; the antibody binds to MNV-1 deposited as American Type Culture Collection (ATCC) Deposit No. PTA-5935 or to a polypeptide encoded by it |
| 02/02/2006 | US20060024279 Retroviral vectors |
| 02/02/2006 | US20060024274 Retroviral vectors |
| 02/02/2006 | DE19856463B4 Retrovirale, mit LCMV pseudotypisierte Hybrid-Vektoren Retroviral pseudotyped with LCMV hybrid vectors |
| 02/02/2006 | CA2571261A1 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 02/01/2006 | EP1621635A2 Self-assembling recombinant HP16 papillomavirus capsid proteins |
| 02/01/2006 | EP1621612A1 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 02/01/2006 | EP1621554A1 Immunoglobulins devoid of light chains |
| 02/01/2006 | EP1621213A1 Ocular gene therapy |
| 02/01/2006 | EP1620558A1 Viral vectors expressing fusion of viral large envelope protein and protein of interest |
| 02/01/2006 | EP1402025B1 Chimaeric phages |
| 02/01/2006 | EP0996738B1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/01/2006 | CN1239699C Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon |
| 02/01/2006 | CN1239697C Large brill rhabdo virus toxic strain and its preparation method and application |
| 02/01/2006 | CN1239696C Lefteye flounder lymph tumour virus toxic strain, its preparation method and application |
| 01/31/2006 | US6991929 Hepatitis A vaccines |
| 01/31/2006 | US6991899 transgenic mink lung cells (which express human furin) which show increased sensitivity to infection or are capable of enhanced productivity of infectious virion; drug screening; kits; vaccines |
| 01/31/2006 | US6991795 fusing nucleic acid sequence encoding peptide or protein to be delivered to a modified papillomavirus L2 gene to create a fusion protein gene, expressing gene to form fusion protein, forming virus-like particle, delivering to cell |
| 01/26/2006 | WO2005103272A3 Pan cancer oncolytic vectors and methods of use thereof |
| 01/26/2006 | WO2004113494A3 Methods for producing preparations of recombinant aav virions substantially free of empty capsids |
| 01/26/2006 | WO2004018630A3 Recombinant double-stranded rna phages and uses thereof |
| 01/26/2006 | US20060019394 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 01/26/2006 | US20060019382 Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors |
| 01/26/2006 | US20060019369 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion |
| 01/26/2006 | US20060019350 Recombinant negative strand RNA virus expression system and vacccines |
| 01/26/2006 | US20060019245 HCV variants |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060018930 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/26/2006 | US20060018928 Virus-like particle containing a dengue virus recombinant replicon |
| 01/26/2006 | US20060018927 Major nucleocapsid protein/phosphoprotein, large polymerase protein, a M2 (ORF1) RNA polymerase elongation factor, and RSV genome/antigenome of human strains; point mutations; glycoproteins; immunogens |
| 01/26/2006 | US20060018884 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 01/26/2006 | US20060018841 AAV vectors for gene delivery to the lung |
| 01/26/2006 | US20060018836 Method for treating human tumor cells with a newcastle disease virus strain having a p53 independent oncolytic effect |
| 01/26/2006 | CA2570975A1 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays |
| 01/25/2006 | EP1618889A2 Influenza Vaccine |
| 01/25/2006 | EP1618888A1 Production of human papillomavirus capsid protein and virus-like particles |
| 01/25/2006 | EP1618191A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/25/2006 | EP1618127A2 The severe acute respiratory syndrome coronavirus |